UMCG

NEWS

    • Announcement: Paper published in Nature Communications

      Announcement: Paper published in Nature Communications

      We are delighted to announce that the results of the clinical phase II study on image-guided surgery using bevacizumab-IRDye800CW in patients with primary breast cancer is published in the journal Nature Communications (2017 impact factor: 12.353) We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes. The full citation is: Koller M, QiuRead more →

    • Award winners EMIM 2018

      Award winners EMIM 2018

      Young Investigator Award Last Friday Marjory Koller was one of the three finalist competing for the young investigator award at the European Molecular Imaging Meeting 2018 in San Sebastian, Spain. During a plenary session she presented our work entitled: ”Quantitative Fluorescence Endoscopy: a new and promising tool to Predict and Evaluate Response to neoadjuvant chemoradiotherapyRead more →

    • Announcement: Paper published in the journal Gut

      Announcement: Paper published in the journal Gut

      We are happy to announce that the paper of our clinical trial in patients with a Barrett’s Oesophagus is published online in the journal Gut, a leading international journal in gastroenterology and hepatology (2016 impact factor: 16.658) We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes. The fullRead more →

    • New clinical trial started: collaboration between OMIG/UMCG-EMI-LUMC

      New clinical trial started: collaboration between OMIG/UMCG-EMI-LUMC

      Recently we started a phase II-b multicenter study that aims to further characterize the performance of EMI-137, a fluorescent compound targeting c-Met, for detection of dysplastic colorectal polyps during colonoscopy. In this study, patients with a high suspicion of colorectal cancer (CRC) that are scheduled to undergo a colonoscopy will be enrolled. Study patients willRead more →

    Our Team

    • Gooitzen van Dam
      Principal Investigator

    • Wouter Nagengast
      Principal Investigator

    • Max Witjes
      Principal Investigator

    • Schelto Kruijff
      Principal Investigator